Search research articles
Contact Us
Filters
Showing results (91-100 of 157) with videos related to
Page
of 16
Sort By:
Plos One
|
September 22, 2011
Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin
Vanniarajan Ayyasamy, Kjerstin M Owens, Mohamed Mokhtar Desouki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 5, 2011
Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation
James A Bonner, Christopher D Willey, Eddy S Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region
Buck E Rogers, Peter L Roberson, Sui Shen, et al.
Molecular Pharmacology
|
April 28, 2009
Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1
Jun Li, Yun Wang, Chaozhe Yang, et al.
Gynecologic Oncology
|
December 14, 2011
The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells
Jenny M Whitworth, Angelina I Londoño-Joshi, Jeffrey C Sellers, et al.
Drug Discovery Today
|
June 21, 2020
PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity
Gary A Piazza, Antonio Ward, Xi Chen, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G Oliver, Albert F LoBuglio, Tong Zhou, et al.
Gynecologic Oncology
|
January 8, 2008
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model
James E Kendrick, J Michael Straughn, Patsy G Oliver, et al.
Oncotarget
|
February 25, 2016
Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer
K Adam Morrow, Shamik Das, Erhong Meng, et al.
Proteomics
|
November 18, 2015
Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer
Michael R Ludwig, Kyoko Kojima, Gregory J Bowersock, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 157) with videos related to
Sort By:
Page
of 16
Plos One
|
September 22, 2011
Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin
Vanniarajan Ayyasamy, Kjerstin M Owens, Mohamed Mokhtar Desouki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 5, 2011
Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation
James A Bonner, Christopher D Willey, Eddy S Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region
Buck E Rogers, Peter L Roberson, Sui Shen, et al.
Molecular Pharmacology
|
April 28, 2009
Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1
Jun Li, Yun Wang, Chaozhe Yang, et al.
Gynecologic Oncology
|
December 14, 2011
The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells
Jenny M Whitworth, Angelina I Londoño-Joshi, Jeffrey C Sellers, et al.
Drug Discovery Today
|
June 21, 2020
PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity
Gary A Piazza, Antonio Ward, Xi Chen, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G Oliver, Albert F LoBuglio, Tong Zhou, et al.
Gynecologic Oncology
|
January 8, 2008
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model
James E Kendrick, J Michael Straughn, Patsy G Oliver, et al.
Oncotarget
|
February 25, 2016
Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer
K Adam Morrow, Shamik Das, Erhong Meng, et al.
Proteomics
|
November 18, 2015
Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer
Michael R Ludwig, Kyoko Kojima, Gregory J Bowersock, et al.
Page
of 16